The lancet oncology
-
The lancet oncology · Aug 2013
Multicenter Study Comparative StudyHormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study.
Few biomarkers of ovarian cancer prognosis have been established, partly because subtype-specific associations might be obscured in studies combining all histopathological subtypes. We examined whether tumour expression of the progesterone receptor (PR) and oestrogen receptor (ER) was associated with subtype-specific survival. ⋯ Carraresi Foundation and others.